However, our analysis did not reveal any significant association between the expression levels of TSP50/p-AKT/ALDH1 and clinical parameters such as patient age or the presence of axillary lymph node metastases (Fig. 12H and I). Here, PRSS50 is linked to metastatic malignant neoplasm in the lymph nodes.